Mojtaba Zehtabi
Overview
Explore the profile of Mojtaba Zehtabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gale Dari M, Ghaedrahmati F, Moalemnia A, Dezfouli M, Savari F, Zamani A, et al.
Curr Mol Med
. 2025 Feb;
PMID: 39957702
Breast cancer is a heterogeneous disease and highly prevalent malignancy affecting women globally. Breast cancer treatments have been demonstrated to elicit significant and long-lasting effects on various aspects of a...
2.
Zehtabi M, Ghaedrahmati F, Gale Dari M, Moramezi F, Kempisty B, Mozdziak P, et al.
Clin Transl Oncol
. 2024 Dec;
PMID: 39661239
MicroRNAs (miRNAs) have emerged as important regulators of gene expression in various biological processes, including cancer. miR-182-5p has gained attention for its potential implications in gynecologic cancers, including breast, ovarian,...
3.
Niebora J, Wozniak S, Domagala D, Data K, Farzaneh M, Zehtabi M, et al.
Front Oncol
. 2024 Aug;
14:1418005.
PMID: 39188680
Endometrial cancer (EC) is one of the most common gynecologic cancers. In recent years, research has focused on the genetic characteristics of the tumors to detail their prognosis and tailor...
4.
Kulus M, Farzaneh M, Bryja A, Zehtabi M, Azizidoost S, Gale Dari M, et al.
Stem Cell Rev Rep
. 2024 Feb;
20(4):967-979.
PMID: 38372877
Epithelial-mesenchymal transition (EMT) is a crucial process with significance in the metastasis of malignant tumors. It is through the acquisition of plasticity that cancer cells become more mobile and gain...
5.
Ghasemian M, Zehtabi M, Gale Dari M, Pour F, Azizi Tabesh G, Moramezi F, et al.
BMC Cancer
. 2024 Jan;
24(1):4.
PMID: 38166752
Long non-coding RNA (lncRNA) H19 has gained significant recognition as a pivotal contributor to the initiation and advancement of gynecologic cancers, encompassing ovarian, endometrial, cervical, and breast cancers. H19 exhibits...
6.
Bryja A, Zadka L, Farzaneh M, Zehtabi M, Ghasemian M, Dyszkiewicz-Konwinska M, et al.
Life Sci
. 2023 Sep;
332:122126.
PMID: 37769803
Small extracellular vesicles (sEVs) are a type of membranous vesicles that can be released by cells into the extracellular space. The relationship between sEVs and non-coding RNAs (ncRNAs) is highly...
7.
Karimi A, Jafari-Koshki T, Zehtabi M, Kargar F, Gheit T
Cancer Med
. 2023 Jul;
12(17):17592-17602.
PMID: 37492996
Background: HPV infection can cause cancer, and standard treatments often result in recurrence. The extent to which liquid biopsy using HPV circulating tumor DNA (HPV ctDNA) can be used as...
8.
Zehtabi M, Akbarpour Z, Valizadeh S, Roosta Y, Mahdi Khamaneh A, Raeisi M
Mol Biol Res Commun
. 2023 Feb;
11(4):173-181.
PMID: 36777002
Papillary thyroid carcinoma (PTC) is the most common endocrine cancer. However, the role of biomechanics in the development and progression of PTC is obscure. The microarray dataset GSE104005 was examined...
9.
Valizadeh S, Zehtabi M, Feiziordaklou N, Akbarpour Z, Mahdi Khamaneh A, Raeisi M
Mol Biol Res Commun
. 2023 Jan;
11(3):133-141.
PMID: 36718241
Papillary thyroid carcinoma (PTC) accounts for approximately 80% of all human thyroid malignancies. Recently, there has been a dramatic rise in the prevalence of thyroid cancer all over the globe....
10.
Raeisi M, Zehtabi M, Velaei K, Fayyazpour P, Aghaei N, Mehdizadeh A
Cell Biol Int
. 2022 Aug;
46(11):1717-1728.
PMID: 36030535
Malignantly transformed cells must alter their metabolic status to stay viable in a harsh microenvironment and maintain their ability to invade and spread. Anoikis, a specific detachment-related form of apoptotic...